cisapride has been researched along with Body Weight in 8 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a double-blind trial, 12 out-patients with primary anorexia nervosa received, for six weeks, either 10 mg cisapride or placebo, three times a day." | 9.07 | Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. ( Abatzi-Wenzel, TA; Bergmann, H; Gaupmann, G; Schneider, C; Stacher, G; Wiesnagrotzki, S, 1993) |
| "In a double-blind trial, 12 out-patients with primary anorexia nervosa received, for six weeks, either 10 mg cisapride or placebo, three times a day." | 5.07 | Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. ( Abatzi-Wenzel, TA; Bergmann, H; Gaupmann, G; Schneider, C; Stacher, G; Wiesnagrotzki, S, 1993) |
| "We conducted a 12-month trial of cisapride (10 mg three times a day) in 21 patients with gastric stasis due to clinically and manometrically diagnosed gastroparesis (N = 9; seven due to diabetes) or chronic intestinal pseudo-obstruction (N = 12)." | 5.07 | Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. ( Abell, TL; Camilleri, M; DiMagno, EP; Hench, VS; Malagelada, JR; Zinsmeister, AR, 1991) |
| "Chronic dyspepsia is common in children." | 1.31 | Nutritional implications of chronic dyspepsia in childhood. ( Bartsocas, C; Papadimitriou, A; Papadopoulou, A; Siafakas, C; Vazeou, A, 2002) |
| "Cisapride was administered, i." | 1.30 | Pharmacokinetics of cisapride in horses after intravenous and rectal administration. ( Bowman, KF; Cook, G; Papich, MG; Roberts, MC, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burger, DM | 1 |
| Wiestner, T | 1 |
| Hubler, M | 1 |
| Binder, H | 1 |
| Keiser, M | 1 |
| Arnold, S | 1 |
| Lee, S | 1 |
| Stacher, G | 1 |
| Abatzi-Wenzel, TA | 1 |
| Wiesnagrotzki, S | 1 |
| Bergmann, H | 1 |
| Schneider, C | 1 |
| Gaupmann, G | 1 |
| Cook, G | 1 |
| Papich, MG | 1 |
| Roberts, MC | 1 |
| Bowman, KF | 1 |
| Takeda, M | 1 |
| Mizutani, Y | 1 |
| Yamano, M | 1 |
| Tsukamoto, K | 1 |
| Suzuki, T | 1 |
| Papadopoulou, A | 1 |
| Vazeou, A | 1 |
| Siafakas, C | 1 |
| Papadimitriou, A | 1 |
| Bartsocas, C | 1 |
| Sugiyam, A | 1 |
| Ishida, Y | 1 |
| Satoh, Y | 1 |
| Aoki, S | 1 |
| Hori, M | 1 |
| Akie, Y | 1 |
| Kobayashi, Y | 1 |
| Hashimoto, K | 1 |
| Abell, TL | 1 |
| Camilleri, M | 1 |
| DiMagno, EP | 1 |
| Hench, VS | 1 |
| Zinsmeister, AR | 1 |
| Malagelada, JR | 1 |
2 trials available for cisapride and Body Weight
| Article | Year |
|---|---|
Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride.
Topics: Adult; Anorexia Nervosa; Body Weight; Cisapride; Dose-Response Relationship, Drug; Double-Blind Meth | 1993 |
Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.
Topics: Administration, Oral; Adult; Body Weight; Chronic Disease; Cisapride; Double-Blind Method; Female; G | 1991 |
6 other studies available for cisapride and Body Weight
| Article | Year |
|---|---|
Effect of anticholinergics (atropine, glycopyrrolate) and prokinetics (metoclopramide, cisapride) on gastric motility in beagles and labrador retrievers.
Topics: Animals; Atropine; Body Weight; Breeding; Cisapride; Dogs; Dose-Response Relationship, Drug; Electro | 2006 |
Gastric emptying and bloating in anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Body Image; Body Weight; Cisapride; Dyspepsia; Female; Gastric Emptying; Ho | 1993 |
Pharmacokinetics of cisapride in horses after intravenous and rectal administration.
Topics: Absorption; Administration, Rectal; Animals; Body Weight; Chromatography, High Pressure Liquid; Cisa | 1997 |
Gastric emptying in diabetic gastroparetic dogs: ffects of SK-951,a novel prokinetic agent.
Topics: Acetaminophen; Animals; Benzofurans; Blood Glucose; Body Weight; Bridged Bicyclo Compounds, Heterocy | 2001 |
Nutritional implications of chronic dyspepsia in childhood.
Topics: Body Weight; Child; Chronic Disease; Cisapride; Dyspepsia; Female; Gastric Emptying; Humans; Male; N | 2002 |
Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs.
Topics: Animals; Arrhythmias, Cardiac; Atrioventricular Node; Blood Pressure; Body Weight; Cisapride; Dogs; | 2002 |